KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Account Payables (2016 - 2026)

TherapeuticsMD filings provide 17 years of Change in Account Payables readings, the most recent being -$340000.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 314.63% to -$340000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$139000.0, a 475.68% decrease, with the full-year FY2025 number at $119000.0, down 48.48% from a year prior.
  • Change in Account Payables hit -$340000.0 in Q1 2026 for TherapeuticsMD, down from $114000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $174000.0 in Q2 2025 to a low of -$818000.0 in Q2 2023.
  • Median Change in Account Payables over the past 5 years was -$82000.0 (2025), compared with a mean of -$196235.3.
  • Biggest five-year swings in Change in Account Payables: tumbled 946.84% in 2023 and later surged 4250.0% in 2025.
  • TherapeuticsMD's Change in Account Payables stood at $79000.0 in 2022, then tumbled by 946.84% to -$669000.0 in 2023, then soared by 103.59% to $24000.0 in 2024, then skyrocketed by 375.0% to $114000.0 in 2025, then plummeted by 398.25% to -$340000.0 in 2026.
  • The last three reported values for Change in Account Payables were -$340000.0 (Q1 2026), $114000.0 (Q4 2025), and -$87000.0 (Q3 2025) per Business Quant data.